-
121
-
122
Representing unsegmented vessels using available vascular data for bioheat transfer simulation
Published 2025-02-01Get full text
Article -
123
Carotid endarterectomy in the setting of persistent hypoglossal artery
Published 2025-02-01Get full text
Article -
124
-
125
-
126
Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy
Published 2024-02-01Get full text
Article -
127
-
128
Case report: A panorama gene profile of ovarian cancer metastasized to axillary lymph node
Published 2025-01-01Get full text
Article -
129
Clinical Oral Health Recommended Care and Oral Health Self-Report, NHANES, 2013-2014
Published 2018-01-01Get full text
Article -
130
On a data-driven mathematical model for prostate cancer bone metastasis
Published 2024-12-01Get full text
Article -
131
-
132
-
133
Development trend of primary healthcare after health reform in China: a longitudinal observational study
Published 2022-06-01Get full text
Article -
134
-
135
-
136
-
137
Plant-nanoparticles enhance anti-PD-L1 efficacy by shaping human commensal microbiota metabolites
Published 2025-02-01Get full text
Article -
138
Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United States
Published 2025-02-01“…Richard S Finn,1 Renuka Iyer,2 Richard S Kalman,3 Neehar D Parikh,4 Roniel Cabrera,5 Svetlana Babajanyan,6 Ahmed O Kaseb7 1Department of Medicine, University of California, Los Angeles, CA, USA; 2Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA; 3Department of Medicine, Einstein Medical Center, Philadelphia, PA, USA; 4Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA; 5Department of Medicine, University of Florida Health, Gainesville, FL, USA; 6US Medical Affairs, Oncology, Bayer Healthcare, Whippany, NJ, USA; 7Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence: Richard S Finn, Department of Medicine, University of California, Los Angeles, CA, USA, Tel +1-310-586-2091, Email rfinn@mednet.ucla.eduIntroduction: While several systemic therapies are available for unresectable hepatocellular carcinoma (uHCC), there is a lack of granular real-world evidence to support the efficacy and safety of these therapies. …”
Get full text
Article -
139
-
140
Cyclin E1/CDK2 activation defines a key vulnerability to WEE1 kinase inhibition in gynecological cancers
Published 2025-01-01Get full text
Article